BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24334679)

  • 1. Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice.
    Ianzano ML; Croci S; Nicoletti G; Palladini A; Landuzzi L; Grosso V; Ranieri D; Dall'Ora M; Santeramo I; Urbini M; De Giovanni C; Lollini PL; Nanni P
    Oncotarget; 2014 Jan; 5(1):108-19. PubMed ID: 24334679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
    Nanni P; Nicoletti G; De Giovanni C; Croci S; Astolfi A; Landuzzi L; Di Carlo E; Iezzi M; Musiani P; Lollini PL
    Cancer Res; 2003 Jun; 63(11):2728-32. PubMed ID: 12782574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
    Li B; Rosen JM; McMenamin-Balano J; Muller WJ; Perkins AS
    Mol Cell Biol; 1997 Jun; 17(6):3155-63. PubMed ID: 9154814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX
    Oncogene; 2001 Mar; 20(12):1445-54. PubMed ID: 11313888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas.
    Stoicănescu D; Andreescu N; Belengeanu A; Meszaros N; Cornianu M
    Rom J Morphol Embryol; 2013; 54(4):1107-13. PubMed ID: 24399009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
    Taneja P; Maglic D; Kai F; Sugiyama T; Kendig RD; Frazier DP; Willingham MC; Inoue K
    Cancer Res; 2010 Nov; 70(22):9084-94. PubMed ID: 21062982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.
    De Giovanni C; Nicoletti G; Palladini A; Croci S; Landuzzi L; Antognoli A; Murgo A; Astolfi A; Ferrini S; Fabbi M; Orengo AM; Amici A; Penichet ML; Aurisicchio L; Iezzi M; Musiani P; Nanni P; Lollini PL
    Hum Gene Ther; 2009 May; 20(5):453-64. PubMed ID: 19215191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression.
    Pannellini T; Spadaro M; Di Carlo E; Ambrosino E; Iezzi M; Amici A; Lollini PL; Forni G; Cavallo F; Musiani P
    J Immunol; 2006 Jun; 176(12):7695-703. PubMed ID: 16751417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.
    Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ
    J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.
    Croci S; Landuzzi L; Nicoletti G; Palladini A; Antognoli A; De Giovanni C; Nanni P; Lollini PL
    Pathol Oncol Res; 2007; 13(4):336-9. PubMed ID: 18158569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast.
    Xu R; Feiner H; Li P; Yee H; Inghirami G; Delgado Y; Perle MA
    Arch Pathol Lab Med; 2003 Nov; 127(11):1458-64. PubMed ID: 14567723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.
    Comiskey DF; Jacob AG; Sanford BL; Montes M; Goodwin AK; Steiner H; Matsa E; Tapia-Santos AS; Bebee TW; Grieves J; La Perle K; Boyaka P; Chandler DS
    Oncogene; 2018 Jan; 37(1):95-106. PubMed ID: 28892044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
    Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
    Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological prevention of a multigene cancer syndrome.
    Croci S; Nicoletti G; Landuzzi L; De Giovanni C; Astolfi A; Marini C; Di Carlo E; Musiani P; Forni G; Nanni P; Lollini PL
    Cancer Res; 2004 Nov; 64(22):8428-34. PubMed ID: 15548714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas.
    Landuzzi L; Ianzano ML; Nicoletti G; Palladini A; Grosso V; Ranieri D; Dall'Ora M; Raschi E; Laranga R; Gambarotti M; Picci P; De Giovanni C; Nanni P; Lollini PL
    Oncotarget; 2014 Dec; 5(23):11924-38. PubMed ID: 25426555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
    Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
    Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.
    Ismail MF; Aly MS; Khaled HM; Mohamed HM
    Ger Med Sci; 2009 May; 7():Doc03. PubMed ID: 19675743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.